tirzepatide is the same as mounjaro vs Mounjaro: What's Difference? Mounjaro (Tirzepatide) Side Effects: What

In an email, Genna Hymowitz, director of metabolic and bariatric psychology and a clinical associate professor at Stony Brook Medicine, said more research was needed "before we prescribe GLP-1s to people who are not overweight, and we need to better understand the long-term risks of GLP-1s

However, individual baseline testing should guide whether additional targeted supplementation is necessary

Common side effects include nausea, vomiting, diarrhea, constipation, and abdominal pain, especially when starting treatment or increasing the dose

Regulating blood sugar effectively

If cholelithiasis is suspected, gallbladder studies and appropriate clinical follow-up are indicated." [3] Patients with prior gallbladder disease, obesity-related fatty liver disease, or a personal or family history of gallstones should discuss gallbladder monitoring with their prescriber before starting a GLP-1 agent